Matches in SemOpenAlex for { <https://semopenalex.org/work/W2227396938> ?p ?o ?g. }
- W2227396938 endingPage "1102" @default.
- W2227396938 startingPage "1094" @default.
- W2227396938 abstract "A multicenter, double-blind, randomized, active-control phase III clinical trial was performed to assess the immunogenicity and safety of a trivalent, inactivated split influenza vaccine. Korean children between the ages of 6 months and 18 y were enrolled and randomized into a study (study vaccine) or a control vaccine group (commercially available trivalent, inactivated split influenza vaccine) in a 5:1 ratio. Antibody responses were determined using hemagglutination inhibition assay, and post-vaccination immunogenicity was assessed based on seroconversion and seroprotection rates. For safety assessment, solicited local and systemic adverse events up to 28 d after vaccination and unsolicited adverse events up to 6 months after vaccination were evaluated. Immunogenicity was assessed in 337 and 68 children of the study and control groups. In the study vaccine group, seroconversion rates against influenza A/H1N1, A/H3N2, and B strains were 62.0% (95% CI: 56.8–67.2), 53.4% (95% CI: 48.1–58.7), and 54.9% (95% CI: 48.1–60.2), respectively. The corresponding seroprotection rates were 95.0% (95% CI: 92.6–97.3), 93.8% (95% CI: 91.2–96.4), and 95.3% (95% CI: 93.0–97.5). The lower 95% CI limits of the seroconversion and seroprotection rates were over 40% and 70%, respectively, against all strains. Seroconversion and seroprotection rates were not significantly different between the study and control vaccine groups. Furthermore, the frequencies of adverse events were not significantly different between the 2 vaccine groups, and no serious vaccination-related adverse events were noted. In conclusion, the study vaccine exhibited substantial immunogenicity and safety in Korean children and is expected to be clinically effective." @default.
- W2227396938 created "2016-06-24" @default.
- W2227396938 creator A5013971587 @default.
- W2227396938 creator A5024164735 @default.
- W2227396938 creator A5025869599 @default.
- W2227396938 creator A5027206485 @default.
- W2227396938 creator A5030486775 @default.
- W2227396938 creator A5039552388 @default.
- W2227396938 creator A5049046821 @default.
- W2227396938 creator A5056018098 @default.
- W2227396938 creator A5059273559 @default.
- W2227396938 creator A5059278035 @default.
- W2227396938 creator A5065025555 @default.
- W2227396938 creator A5066538135 @default.
- W2227396938 creator A5077093336 @default.
- W2227396938 creator A5081731045 @default.
- W2227396938 creator A5085509776 @default.
- W2227396938 creator A5087581036 @default.
- W2227396938 date "2015-04-15" @default.
- W2227396938 modified "2023-10-18" @default.
- W2227396938 title "Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial" @default.
- W2227396938 cites W1482039347 @default.
- W2227396938 cites W1531645323 @default.
- W2227396938 cites W1973552027 @default.
- W2227396938 cites W1977461039 @default.
- W2227396938 cites W1977775160 @default.
- W2227396938 cites W1983669467 @default.
- W2227396938 cites W1997791400 @default.
- W2227396938 cites W2015260696 @default.
- W2227396938 cites W2020267521 @default.
- W2227396938 cites W2021773824 @default.
- W2227396938 cites W2027393202 @default.
- W2227396938 cites W2028806345 @default.
- W2227396938 cites W2036251006 @default.
- W2227396938 cites W2036767419 @default.
- W2227396938 cites W2047198617 @default.
- W2227396938 cites W2047370146 @default.
- W2227396938 cites W2055484372 @default.
- W2227396938 cites W2063163439 @default.
- W2227396938 cites W2070433339 @default.
- W2227396938 cites W2074792583 @default.
- W2227396938 cites W2078475500 @default.
- W2227396938 cites W2100279349 @default.
- W2227396938 cites W2104763392 @default.
- W2227396938 cites W2105133296 @default.
- W2227396938 cites W2111831969 @default.
- W2227396938 cites W2122922626 @default.
- W2227396938 cites W2126418616 @default.
- W2227396938 cites W2130947935 @default.
- W2227396938 cites W2145230724 @default.
- W2227396938 cites W2151926553 @default.
- W2227396938 cites W2312219549 @default.
- W2227396938 cites W2785073138 @default.
- W2227396938 cites W4210821617 @default.
- W2227396938 cites W2394847568 @default.
- W2227396938 doi "https://doi.org/10.1080/21645515.2015.1017693" @default.
- W2227396938 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4514431" @default.
- W2227396938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25875868" @default.
- W2227396938 hasPublicationYear "2015" @default.
- W2227396938 type Work @default.
- W2227396938 sameAs 2227396938 @default.
- W2227396938 citedByCount "4" @default.
- W2227396938 countsByYear W22273969382017 @default.
- W2227396938 countsByYear W22273969382018 @default.
- W2227396938 countsByYear W22273969382022 @default.
- W2227396938 crossrefType "journal-article" @default.
- W2227396938 hasAuthorship W2227396938A5013971587 @default.
- W2227396938 hasAuthorship W2227396938A5024164735 @default.
- W2227396938 hasAuthorship W2227396938A5025869599 @default.
- W2227396938 hasAuthorship W2227396938A5027206485 @default.
- W2227396938 hasAuthorship W2227396938A5030486775 @default.
- W2227396938 hasAuthorship W2227396938A5039552388 @default.
- W2227396938 hasAuthorship W2227396938A5049046821 @default.
- W2227396938 hasAuthorship W2227396938A5056018098 @default.
- W2227396938 hasAuthorship W2227396938A5059273559 @default.
- W2227396938 hasAuthorship W2227396938A5059278035 @default.
- W2227396938 hasAuthorship W2227396938A5065025555 @default.
- W2227396938 hasAuthorship W2227396938A5066538135 @default.
- W2227396938 hasAuthorship W2227396938A5077093336 @default.
- W2227396938 hasAuthorship W2227396938A5081731045 @default.
- W2227396938 hasAuthorship W2227396938A5085509776 @default.
- W2227396938 hasAuthorship W2227396938A5087581036 @default.
- W2227396938 hasBestOaLocation W22273969381 @default.
- W2227396938 hasConcept C126322002 @default.
- W2227396938 hasConcept C159654299 @default.
- W2227396938 hasConcept C168563851 @default.
- W2227396938 hasConcept C197934379 @default.
- W2227396938 hasConcept C203014093 @default.
- W2227396938 hasConcept C22070199 @default.
- W2227396938 hasConcept C2776872762 @default.
- W2227396938 hasConcept C2777451964 @default.
- W2227396938 hasConcept C2780689484 @default.
- W2227396938 hasConcept C2780868878 @default.
- W2227396938 hasConcept C2909469553 @default.
- W2227396938 hasConcept C535046627 @default.
- W2227396938 hasConcept C71924100 @default.
- W2227396938 hasConceptScore W2227396938C126322002 @default.
- W2227396938 hasConceptScore W2227396938C159654299 @default.